Matucci-Cerinic M, Fattorini L, Gerini G, Lombardi A, Pignone A, Petrini N, Lotti T
Istituto di Clinica Medica IV, Università di Firenze, Italy.
Rheumatol Int. 1988;8(4):185-8. doi: 10.1007/BF00270458.
We report a case of pachydermoperiostosis with arthralgia, acroosteolysis, and recurrent staphylococcal folliculitis of the face, treated with colchicine (0.5 mg once daily for the 1st week and 0.5 mg twice daily for the next 3 weeks). The evaluation of arthralgia, hyponchial angle, folliculitis, and pachyderma, performed at basal time and once weekly, showed improvement of symptoms and signs after 7-15 days of treatment. Neutrophilic chemotaxis, evaluated before starting the treatment and after 15 and 30 days of therapy, showed a progressive decrease of the initial very high index. Colchicine provided a beneficial therapeutic response in both inhibiting increased chemotactic activity and in reducing tissular oedema in our patient.
我们报告一例厚皮性骨膜病患者,伴有关节痛、肢端骨质溶解和面部复发性葡萄球菌性毛囊炎,采用秋水仙碱治疗(第1周每日1次,每次0.5 mg,接下来3周每日2次,每次0.5 mg)。在基线期和每周一次对关节痛、指(趾)骨角、毛囊炎和厚皮病进行评估,结果显示治疗7 - 15天后症状和体征有所改善。在治疗开始前以及治疗15天和30天后评估中性粒细胞趋化性,结果显示最初非常高的指数逐渐下降。秋水仙碱在抑制趋化活性增加和减轻患者组织水肿方面均产生了有益的治疗反应。